Enzyme (MLN) announced its integration with the Chainlink Runtime Environment (CRE) to enhance institutional tokenized product administration, effective November 6, 2025.

The integration anticipates attracting institutional investors to DeFi, augmenting security and compliance, potentially boosting MLN token credibility and usage in DeFi markets.

Enzyme Integrates Chainlink CRE for Institutional Product Administration

Enzyme partners with Chainlink to enhance institutional DeFi solutions through the CRE integration.

Enzyme Leverages Chainlink for Institutional Asset Management

Enzyme (MLN) has announced an integration with Chainlink to adopt the Chainlink Runtime Environment (CRE). The initiative is designed to enhance institutional tokenized product administration, marking a significant step forward in on-chain asset management.

Both Enzyme and Chainlink are central to this collaboration. Enzyme will leverage CRE for compliance and execution enhancements, responding to the needs of institutional stakeholders eager for secure and transparent DeFi solutions.

Chainlink CRE Integration Spurs Institutional DeFi Growth

Integrating with Chainlink CRE is positioned as a catalyst for scaling institutional DeFi products. This aims to attract engagement from banks, asset managers, and custodians, potentially increasing usage of Enzyme’s platform.

The financial sector, including major entities, is already engaging with CRE. This aligns with the trend towards institutional allocation in DeFi, driving forward on-chain asset management adoption through implementing compliance-ready tokenized products.

Chainlink CRE Mirrors Ethereum’s Impact, Say Experts

The adoption of the Ethereum Virtual Machine in 2015 marked a transformational change similar to the current Chainlink CRE integration for DeFi. Implementations like Kiln and others demonstrate the potential for breakthrough institutional DeFi scaling.

Laszlo Szabo, Co-Founder & CEO at Kiln, stated, “We’re excited to integrate the Chainlink Runtime Environment (CRE) and Automated Compliance Engine (ACE) as critical components for bringing a new generation of onchain asset management products to market. With CRE, we can execute institutional strategies securely and transparently, while ACE enables the access controls and compliance policies that institutions require. Launching these new products serves as a model for how secure, permissioned DeFi can scale across ecosystems.”

Experts suggest that Enzyme’s move mirrors past successful integrations which unlocked multibillion-dollar DeFi ecosystems. This development promises enhanced security and embedded compliance, potentially boosting institutional participation significantly.

Disclaimer: This website provides information only and is not financial advice. Cryptocurrency investments are risky. We do not guarantee accuracy and are not liable for losses. Conduct your own research before investing.